Medical treatments of hyperactif child: About the new pharmaceutical forms of methylphenidate marketed in France;Traitements médicaux de l'enfant hyperactif: À propos des deux nouvelles formes de méthylphénidate commercialisées en France

Archives de Pediatrie

Volumn 13, Issue 1, 2006, Pages 100-103

  Le Heuzey, M F ^a   Vergnaud, S ^a   Mouren, M C ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

ADHD; Attention deficit hyperactivity disorder; Methylphenidate; Sustained Release methylphenidate

Indexed keywords

METHYLPHENIDATE; RITALINE;

ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CLINICAL ARTICLE; DRUG CAPSULE; FRANCE; HUMAN; SUSTAINED DRUG RELEASE; TREATMENT OUTCOME;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DELAYED-ACTION PREPARATIONS; FEMALE; FRANCE; HUMANS; MALE; METHYLPHENIDATE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 30144437434     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2005.09.007     Document Type: Article

References (9)

1. MTA Cooperative group National institute of mental health multimodal treatment study of ADHD follow up: 24:month outcomes of treatment strategies for attention deficit hyperactivity disorder Pediatrics 113 2004 754 761
2. H. Abikoff, L. Hechtman, R.-G. Klein, G. Weiss, K. Fleiss, and J. Etcovitch Symptomatic improvement in children with ADHD treated with long term methylphenidate and multimodal psychosocial treatment J. Am. Acad. Child. Adolesc. Psychiatry 43 2004 802 811
3. E. Taylor, M. Dopfner, J. Sergeant, P. Asherson, T. Banaschewski, and J. Buitelaar European clinical guidelines for hyperkinetic disorder - first upgrade Eur. Child. Adolesc. Psychiatry 13 Suppl. 1 2004 17 30
4. M. Bouvard, M.-F. Le Heuzey, and M.-C. Mouren-Simeoni L'hyperactivit́, de l'enfance ̀ l'âge adulte 2002 Éditions Doin Paris
5. M.-F. Le Heuzey Les traitements ḿdicaux de l'enfant hyperactif Arch. Pediatr. 11 1 2004 64 69
6. J. Swanson, S. Gupta, A. Lam, I. Shoulson, M. Lerner, and N. Modi Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies Arch. Gen. Psychiatry 60 2 2003 204 211
7. M.D. Rappley Attention deficit-hyperactivity disorder N. Engl. J. Med. 352 2005 165 173
8. Prescrire Int. Sustained -release methylphenidate: new preparations. New pharmaceutical forms: a slight advantage for a small number of children 2004; 13(74):203-6.
9. CR. Steer Managing attention deficit/hyperactivity disorder: unmet needs and future directions Arch. Dis. Child. 90 2005 i19 i25